الولايات المتحدة · منصات وبيانات · Stocktwits

Biotech Dealmaker: Early-Stage Platforms And Tools Draw Capital As Full Buyouts Remain On The Sidelines This Week

نشره Stocktwits · الولايات المتحدة منذ 11 س

ملخص مفصل

Large drugmakers and specialized investors continued to favor targeted capability additions, asset purchases, and co-funding arrangements over outright buyouts of late-stage…

اقرأ المقال كاملًا على Stocktwits سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (stocktwits.com)

يستحق القراءة أيضًا

MarketBeat

Insider Selling: Neuronetics (NASDAQ:STIM) Major Shareholder Sells 86,757 Shares of Company Stock

Investing.com

Global Partners LP general partner acquires $442,475 in common units

MarketWatch

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

Seeking Alpha

Loma Negra GAAP EPS of Arg$26.07, revenue of Arg$270.1B

CNBC

Lutnick faces questions over Nvidia spy scandal. His sons' firm has deep ties to the chipmaker

Benzinga